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Lactotransferrin, also known as lactoferrin, is an iron binding glycoprotein that displays antiviral activity against 
many different infectious agents, including human immunodeficiency virus (HIV)-1. Lactotransferrin is present in the 
breast milk and in the female genitourinary mucosa and it has been hypothesised as a possible candidate to prevent moth-
er-to-child HIV-1 transmission. To verify if two functional polymorphisms, Thr29Ala and Arg47Lys, in the lactotransferrin 
encoding gene (LTF) could affect HIV-1 infection and vertical transmission, a preliminary association study was per-
formed in 238 HIV-1 positive and 99 HIV-1 negative children from Brazil, Italy, Africa and India. No statistically signifi-
cant association for the Thr29Ala and Arg47Lys LTF polymorphisms and HIV-1 susceptibility in the studied populations 
was found. Additionally LTF polymorphisms frequencies were compared between the four different ethnic groups.
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In 2013, about 240,000 children acquired human 
immunodeficiency virus (HIV)-1 infection worldwide 
(WHO 2013). The main route of HIV-1 infection for a 
child is through the HIV-1 positive mother, during de-
livery or breastfeeding. Without antiretroviral interven-
tion, caesarean delivery (Legardy-Williams et al. 2010) 
or safer alternatives to breastfeeding, the transmission 
rate of HIV-1 from an infected mother to her infant var-
ies from 30-45% (Datta et al. 1994).
In this context, innate immunity effector molecules 
have an important role in fighting against HIV-1 in-
fection. Among them, lactotransferrin (also known as 
lacto ferrin) seemed to be a possible candidate to prevent 
mother-to-child transmission (MTCT) of the virus. Lac-
totransferrin, in fact, has been reported as possessing 
antiviral activity against HIV-1: through the binding to 
dendritic cell-specific intercellular adhesion molecule-
3-grabbing non-integrin, the protein blocks the attach-
ment to the viral gp120, so the virus transmission from 
dendritic cells to T cells is inhibited (Groot et al. 2005).
Lactotransferrin is found in breast milk and at the mu-
cosal level in the female genitourinary tract (Kazmi et al. 
2006): a reduction in maternal serum lactotransferrin has 
been correlated with increased risk of HIV-1 MTCT (De-
fer et al. 1995, Semba et al. 1998). Reduced lactotransferrin 
serum level have been detected in HIV-1 infected individu-
als compared to healthy controls (Dapsanse et al. 2001) and 
in acquired immune deficiency syndrome (AIDS) patients 
compared to asymptomatic and symptomatic HIV-1 posi-
tive individuals or controls (van der Strate et al. 2001).
The LTF gene (chromosomal localisation: 3p21.3) 
encodes lactotransferrin; more than 60 single nucleotide 
polymorphisms (SNPs) have been identified within the 
promoter region, exons or introns. Two nonsynonymous 
polymorphisms, Thr29Ala and Arg47Lys (rs1126477 and 
rs1126478, respectively) in the first exon of the LTF gene, 
resulting in amino acid changes in the mature peptide and 
located within the strongly basic N-terminal region of the 
protein, that mediates its antibacterial properties (Shan-
bacher et al. 1992) have been described as associated 
with different pathologies, such as periodontitis (Velliya-
gounder et al. 2003, Jordan et al. 2005, Wu et al. 2009), 
dental caries (Azevedo et al. 2010, Fine et al. 2013), ovar-
ian cancer (Cao et al. 2011), nasopharyngeal carcinoma 
(Zhou et al. 2012), dyslipidaemia (Moreno-Navarrete et al. 
2008) and coronary artery stenosis (Videm et al. 2012).
The Thr29Ala amino acid change results from an 
A-G substitution at nucleotide 88 and the Arg47Lys 
change results from an A-G transition at nucleotide 140 
(Teng & Gladwell 2006).
This preliminary study aims at investigating the role 
of these two nonsynonymous SNPs in HIV-1 positive 
newborns infected by vertical transmission and chil-
dren not infected but born from HIV-1 positive mothers, 
in four different populations from Brazil, Italy, Africa 
and India. Frequency differences within the four ethnic 
groups will be also described.
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SUBJECTS, MATERIALS AND METHODS
Patients - Genomic DNAs from 238 HIV-1 positive 
children (all within 6 and 14 years of age; 126 females - 53% 
and 112 males - 47%) were obtained. The sample consisted 
of 78 Brazilian children (40 females and 38 males) from the 
state of Pernambuco, Northeast Region of Brazil, collected 
at the Prof Fernando Figueira Integral Medicine Institute, 
Recife, 89 Italians (49 females and 40 males), collected at 
the Children Hospital Regina Margherita, Turin, 26 Zim-
babwe Africans (14 females and 12 males) and 45 Kerala 
Indians (23 females and 22 males). The last two samples 
both came from a historical cohort kindly provided by Prof 
Trabattoni (Sacco Hospital, Milan, Italy).
The children were infected during delivery [exposed 
infected (EI)]. Ninety-nine exposed uninfected (EU) 
HIV-1 negative children (all within 6 and 14 years of age; 
53 females - 54% and 46 males - 46%; 35 Brazilian, 20 
females and 15 males; 18 Italian, 9 females and 9 males; 
15 Zimbabwe African, 9 females and 6 males; 31 Kera-
la Indians, 15 females and 16 males), born from HIV-1 
positive mothers, were already available at the Labora-
tory of Immunogenetics of Scientific Institute For Rese-
arch, Hospitalization and Care (IRCCS) Burlo Garofolo 
and were used for this study. Biological material from 
the mothers was not available and the sole information 
available to us was that none of the infected mothers un-
derwent antiretroviral therapy before delivery or caesar-
ean section to prevent HIV-1 infection of the newborns.
DNA extraction and SNPs genotyping - DNA extrac-
tion from whole blood was performed using the DNeasy 
Blood and Tissue Kit (Qiagen, Germany), in accordance 
with the manufacturers’ manual.
The two LTF (National Center for Biotechnology 
Information Reference Sequence: NC�000003), func-
tional SNPs, Thr29Ala and Arg47Lys (rs1126477 and 
rs1126478, respectively) were genotyped by real time 
polymerase chain reaction (PCR) using C���9698511�10 
and C���9698521�10 fluorogenic allele-specific TaqMan 
SNPs genotyping assay probes (Applied Biosystems-Life 
Technologies, USA) on the ABI7900HT Real Time PCR 
platform (Applied Biosystems), following manufacturer 
instructions: an initial step for Taq polymerase activation 
at 95ºC for 10 min followed by 40 cycles with 15 s of 95ºC 
for denaturation and 1 min at 60ºC for extension.
Allelic discrimination was done both manually and 
automatically with the SDS detection software (Applied 
Biosystems).
Real time allele specific PCRs results were double 
checked by direct sequencing performed on 50 random-
ly chosen samples and 100% of concordance was found.
Statistical analysis - LTF gene polymorphisms, allele 
and genotype frequencies were calculated by direct count-
ing, while haplotype frequencies were computed using the 
Arlequin software v.3.1 (Excoffier & Lischer 2010).
The Fisher’s exact test for pairwise comparison of 
allele, genotype and haplotype frequencies (using con-
tingency tables as appropriate) was performed with the 
open-source R v.3.1.0 (R Development Core Team 2014). 
Only p values < 0.01 were considered to be significant.
p values for linkage disequilibrium (LD) analy-
sis were calculated using the permutation test with the 
EM algorithm, Arlequin software (Excoffier & Lischer 
2010), whereas D, D’ and r2 measures were computed 
with SNPstat (Sole et al. 2006, Clayton 2013). Post-hoc 
power calculations were performed through G*Power 
software v.3.1.9.2 (Faul et al. 2007).
Ethics - Two independent ethical committees, one 
from IRCCS Burlo Garofolo (protocol L-1106, 1 May 
2010), the other from Prof Fernando Figueira Integral 
Medicine Institute (registration 2273-11), responsible for 
all patients’ biological samples (from 4 populations), ap-
proved the retrospective study.
All study experiments and procedures have been 
performed in accordance with the ethical standards of 
the Declaration of Helsinki.
RESULTS
The genotype frequencies of Thr29Ala and Arg47Lys 
polymorphisms of the LTF gene were assessed in 238 
HIV-1 positive children (EI) and 99 HIV-1 negative 
(EU) children all born from HIV-1 positive women from 
four different populations. The polymorphisms were in 
Hardy-Weinberg equilibrium in all groups, except for 
the Thr29Ala in the EU Indians group and Arg47Lys in 
the EI African group (Tables I, II).
The Thr29Ala A allele was the major allele in the Af-
rican population (76% in the EU and 77% in the EI) and 
in the Brazilian one (51% in the EU and 52% in the EI), 
whereas in Indians and Italians, the A allele was the mi-
nor one (47% in EU and 39% in the EI in Indians and 25% 
in EU and 21% in EI in Italians, respectively) (Table I).
The Arg47Lys A allele was the major allele in the 
Italian population (64% in the EU and 60% in the EI), 
while it was the minor allele in the African population 
(3% in the EU and 4% in the EI), among Indians (34% 
in the EU and 36% in the EI) and Brazilian individuals 
(43% in the EU and 33% in the EI) (Table II).
The frequency data of each population were com-
pared using Fisher’s exact test with the most similar eth-
nic group reported by the HapMap project (International 
HapMap Consortium 2003) and 1000 Genomes project 
(GPC et al. 2012). The Italian population was compared 
with the HapMap-TSI population, Tuscans in Italy; the 
African population with the Sub-Saharan Africa Hap-
Map-YRI population, Yoruba in Ibadan, Nigeria; the 
Brazilian population with 1000 Genomes-AMR popula-
tion, an admixture of Colombian from Medellin, Colom-
bia, Mexican ancestry from Los Angeles, United States 
of America, Puerto Ricans from Puerto Rica; the Indian 
population with 1000 Genomes-ASN population, an ad-
mixture from Han-Chinese in Beijng, China, Southern 
Han Chinese, Japanese in Tokyo, Japan.
The Thr29Ala and Arg47Lys frequencies were simi-
lar (p > 0.05) for the populations from Africa, Italy and 
India. Comparing the Brazilian population of our study 
with an admixed population from 1000 Genomes, AMR 
population (to serve as a proxy to the admixed Brazilian 
populations), the Thr29Ala A allele was more frequent 
in the Brazilian sample (52%) respect to AMR (41%). 
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The Arg47Lys G allele was more represented among 
our Brazilian population than AMR population (57% 
and 47% respectively). Moreover the G/G genotype was 
more frequent in our Brazilian population, whereas A/G 
and A/A genotype were more frequent in the AMR pop-
ulation (Tables III, IV).
Therefore, the allele and genotype frequencies of 
both polymorphisms were not statistically different 
when comparing EI with EU children in our populations 
(Tables I, II).
The Thr29Ala and Arg47Lys polymorphisms were 
in LD (p < 0.07, D’statistic > 0.72; r2 statistic > 0.11 for 
all groups) and combined to form three major haplo-
types (AG, GG and GA, with frequencies > 0.01) and 
one minor (AA, with frequency ≤ 0.01). Comparing the 
haplotype frequencies between EU and EI in the four 
populations, no statistically significant differences were 
observed when using Fisher test with 4 x 2 table (Table 
V). The same results were obtained considering the most 
frequent haplotype as reference and analysing all other 
haplotypes vs. that reference (data not shown).
DISCUSSION
Several biological activities of lactotransferrin against 
HIV-1 have been described so far, ranging from the inhi-
bition of virus-cell interaction through CXCR4 and CCR5 
binding or viral gp120 V3 loop blocking (Berkhout et al. 
2002), to inhibit viral processes within the host cells (Ng 
et al. 2001). Recently, Wong et al. (2014) have shown the 
inhibitory activity of lactotransferrin fragments lacto-
ferricin and lactoferrampin against HIV-1 reverse tran-
scriptase and integrase, respectively.
A reduction of the serum lactotransferrin concentra-
tion has previously been associated with increased HIV-1 
TABLE I
LTF Thr29Ala polymorphism allele, genotype frequencies (and counts) in human immunodeficiency  
virus (HIV) positive (+) and negative (-) children in the four different populations analysed
LTF SNP 
Thr29Ala (rs1126477) HIV- HIV+
HIV- vs. HIV+
p (CI) OR
Africa n = 15 n = 26
A 0.76 (23) 0.77 (40) Reference
G 0.23 (7) 0.23 (12) 1.00 (0.30-3.40) 0.99
A/A 0.60 (9) 0.61 (16) Reference
A/G 0.33 (5) 0.31 (8) 1.00 (0.19-4.64) 0.90
G/G 0.07 (1) 0.08 (2) 1.00 (0.05-73.62) 1.12
HWE (χ2; p) 0.07; 0.79 0.46; 0.50 -
India n = 31 n = 45
A 0.47 (29) 0.39 (35) Reference
G 0.53 (33) 0.61 (55) 0.40 (0.68-2.80) 1.38
A/A 0.13 (4) 0.16 (7) Reference
A/G 0.68 (21) 0.47 (21) 0.51 (0.11-2.68) 0.58
G/G 0.19 (6) 0.38 (17) 0.69 (0.25-9.53) 1.59
HWE (χ2; p)  4.03; 0.04  0.01; 0.90 -
Brazil n = 35 n = 78
A 0.51 (36) 0.52 (81) Reference
G 0.49 (34) 0.48 (75) 1.00; (0.54-1.79) 0.98
A/A 0.31 (11) 0.32 (25) Reference
A/G 0.40 (14) 0.40 (31) 1.00 (0.34-2.78) 0.97
G/G 0.29 (10) 0.28 (22) 1.00 (0.31-3.09) 0.97
HWE (χ2; p) 1.39; 0.24 3.24; 0.07 -
Italy n = 18 n = 89
A 0.25 (9) 0.31 (55) Reference
G 0.75 (27) 0.69 (123) 0.55 (0.56-3.46) 1.34
A/A 0.06 (1) 0.12 (11) Reference
A/G 0.39 (7) 0.37 (33) 1.00; (0.32-3.61) 1.05
G/G 0.56 (10) 0.51 (45) 0.67 (0.28-115.53) 2.42
HWE (χ2; p) 0.02; 0.87 1.54; 0.21 -
CI: confidence interval; HWE: Hardy Weinberg equilibrium; LTF: lactoferrin encoding gene; OR: odds ratio; SNP: single nu-
cleotide polymorphism.
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infection susceptibility (Defer et al. 1995, Semba et al. 
1998, Dapsanse et al. 2001) and AIDS progression (van 
der Strate et al. 2001). Additionally, recent works have 
explored the role of lactotransferrin in the oral health 
among HIV-1 infected subjects. Alves et al. (2014) ob-
served higher salivary lactotransferrin levels in HIV-1 
infected children during Candida sp. oral colonisation. 
Ferreira et al. (2014) reported no lactotransferrin level 
alterations in gingival crevicular fluid and saliva from 
HIV-1 infected subjects with chronic periodontitis.
To the best of our knowledge, no studies so far in-
vestigated the possible association between LTF genetic 
variants and susceptibility to HIV-1 infection or with 
progression to AIDS and its clinical manifestations.
Two functional polymorphisms within LTF gene, 
named Thr29Ala and Arg47Lys, were previously associ-
ated with an increased susceptibility to periodontitis de-
velopment (Velliyagounder et al. 2003, Jordan et al. 2005, 
Wu et al. 2009), dental caries (Azevedo et al. 2010, Fine et 
al. 2013), ovarian cancer (Cao et al. 2011), nasopharyngeal 
carcinoma (Zhou et al. 2012), dyslipidaemia (Moreno-Na-
varrete et al. 2008) and coronary artery stenosis (Videm et 
al. 2012). In our study, the Thr29Ala and Arg47Lys poly-
morphisms were analysed in order to investigate the pos-
sible role of these LTF genetic variants on HIV-1 MTCT.
Our association analysis, performed among children 
born from HIV-1 positive mothers from four different 
populations, indicates that the LTF Thr29Ala and Ar-
g47Lys allele, genotype and haplotype frequencies, are 
similar in HIV-1 infected and HIV-1 EU children and are 
also comparable to those reported by the HapMap proj-
ect (International HapMap Consortium 2003) and 1000 
Genomes project (GPC et al. 2012); the Brazilian popu-
lation does not follow the same frequency distribution, 
TABLE II
LTF Arg47Lys polymorphism allele, genotype frequencies (and counts) in human immunodeficiency  
virus (HIV) positive (+) and negative (-) children in the four different populations analysed
LTF SNP 
Arg47Lys (rs1126478) HIV- HIV+
HIV- vs. HIV+
p (CI) OR
Africa n = 15 n = 26
G 0.97 (29) 0.96 (50) Reference
A 0.03 (1) 0.04 (2) 1.00 (0.06-70.74) 1.16
G/G 0.93 (14) 0.96 (25) Not calculable
A/G 0.07 (1) 0.00 (0) Not calculable
A/A 0.00 (0) 0.04 (1) Not calculable
HWE (χ2; p) 0.02; 0.89 26; 3.41E-07
India n = 31 n = 45 -
G 0.66 (41) 0.64 (58) Reference
A 0.34 (21) 0.36 (32) 0.86 (0.52-2.26) 1.08
G/G 0.39 (12) 0.38 (17) Reference
A/G 0.55 (17) 0.53 (24) 1.00 (0.34-2.90) 0.99
A/A 0.06 (2) 0.09 (4) 1.00 (0.17-17.82) 1.40
HWE (χ2; p) 1.56; 0.21 1.21; 0.27 -
Brazil n = 35 n = 78
G 0.57 (40) 0.67 (104) Reference
A 0.43 (30) 0.33 (52) 0.18 (0.36-1.24) 0.67
G/G 0.40 (14) 0.49 (38) Reference
A/G 0.34 (12) 0.36 (28) 0.82 (0.31-2.38) 0.86
A/A 0.26 (9) 0.15 (12) 0.26 (0.15-1.64) 0.50
HWE (χ2; p) 3.15; 0.08 2.88; 0.09 -
Italy n = 18 n = 89
G 0.36 (13) 0.40 (71) Reference
A 0.64 (23) 0.60 (107) 0.71 (0.53-2.70) 1.17
G/G 0.06 (1) 0.16 (14) Reference
A/G 0.61 (11) 0.48 (43) 0.79 (0.20-2.45) 0.73
A/A 0.33 (6) 0.36 (32) 0.66 (0.27-129.16) 2.58
HWE (χ2; p) 1.89; 0.17 0.005; 0.94 -
CI: confidence interval; HWE: Hardy Weinberg equilibrium; LTF: lactoferrin encoding gene; OR: odds ratio; SNP: single 
nucleotide polymorphism.
226 Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 110(2), April 2015
probably due to the ethnic heterogeneity among Brazil-
ians, that are an admixture of African, Caucasian and 
native American populations (Alves-Silva et al. 2000), 
and considering that the AMR population that was used 
as a comparison is not a Brazilian one, but is an admix-
ture of Colombian from Medellin, Mexican ancestry 
from Los Angeles and Puerto Ricans.
During descriptive analysis, African and Italian pop-
ulations seemed to present opposite allelic frequencies. 
On the other hand, among the Indian and the Brazil-
ian subjects, the frequencies of the two polymorphisms 
seemed to be similar.
No significant differences were found when compar-
ing HIV-1 positive and HIV-1 negative children, sug-
TABLE III
LTF Thr29Ala polymorphism allele, genotype frequencies (and counts) in human immunodeficiency  
virus (HIV) positive (+) plus negative (-) children in the four different populations compared with  
the most similar ethnic group reported by HapMap and 1000 Genomes project
LTF SNP 
Thr29Ala (rs1126477)
Total
(HIV+ plus HIV-)
HapMap/
1000 Genomes
Total vs. 
Hapmap/
1000 Genomes  
p (CI) OR
Africa
(n = 41)
HapMap-YRIa
(n = 113)
A 0.77 (63) 0.85 (192) Reference
G 0.23 (19) 0.15 (34) 0.12 (0.85-3.32) 1.70
A/A 0.61 (25) 0.70 (79) Reference
A/G 0.32 (13) 0.30 (34) 0.69 (0.50-2.80) 1.21
G/G 0.07 (3) 0.00 (0) Not calculable
India
(n = 76)
1000 Genomes-ASNb
(n = 286)
A 0.42 (64) 0.40 (229) Reference
G 0.58 (88) 0.60 (343) 0.64 (0.63-1.34) 0.92
A/A 0.14 (11) 0.17 (49) Reference
A/G 0.55 (42) 0.46 (131) 0.38 (0.65-3.32) 1.43
G/G 0.30 (23) 0.37 (106) 1.00 (0.41-2.38) 0.97
Brazil
(n = 113)
1000 Genomes-AMRc
(n = 199)
A 0.52 (117) 0.41 (149) Reference
G 0.48 (109) 0.59 (213) 0.01 (0.46-0.92) 0.65
A/A 0.32 (36) 0.19 (34) Reference
A/G 0.40 (45) 0.45 (81) 0.03 (0.28-0.99) 0.53
G/G 0.28 (32) 0.36 (66) 0.02 (0.23-0.90) 0.46
Italy
(n = 107)
HapMap-TSId
(n = 88)
A 0.30 (64) 0.26 (46) Reference
G 0.70 (150) 0.74 (130) 0.43 (0.52-1.32) 0.83
A/A 0.11 (12) 0.06 (5) Reference
A/G 0.37 (40) 0.41 (36) 0.27 (0.12-1.60) 0.47
G/G 0.51 (55) 0.53 (47) 0.29 (0.13-1.63) 0.49
a: Yoruba, Ibadan, Nigeria; b: an admixture from Han-Chinese in Beijng, China, Southern Han Chinese, Japanese in To-
kyo, Japan; c: an admixture of Colombian from Medellin, Colombia, Mexican ancestry from Los Angeles, United States of 
America, Puerto Ricans, from Puerto Rico; d: Toscans, Italy; CI: confidence interval; LTF: lactoferrin encoding gene; OR: 
odds ratio; SNP: single nucleotide polymorphism.
gesting that the two LTF polymorphisms could be not 
involved in HIV-1 vertical transmission. However, the 
data are preliminary and the comparison of the frequen-
cies among the distinct human groups is quite complex 
to be performed: it is not excluded that the lack of as-
sociation may be due in part to the small sample size of 
the populations investigated combined with a small ef-
fect of LTF in HIV-1 susceptibility, a multifactorial trait. 
Indeed, although the total number of analysed individual 
was 337, the classification in HIV-1 positive and nega-
tive and in the four subgroups based on ethnic origins 
led to a reduction of the power of the study. In fact, ex-
cept for the haplotype analysis in the Brazilian popula-
tion (power = 0.96), all other tests had a low power (0.07 
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TABLE IV
LTF Arg47Lys polymorphism allele, genotype frequencies (and counts) in human immunodeficiency  
virus (HIV) positive (+) plus negative (-) children in the four different populations compared with  
the most similar ethnic group reported by HapMap and 1000 Genomes project
LTF SNP 
Arg47Lys (rs1126478)
Total
(HIV+ plus HIV-)
HapMap/
1000 Genomes
Total vs. 
Hapmap/
1000 Genomes  
p (CI) OR
Africa
(n = 41)
HapMap-YRIa
(n = 113)
G 0.97 (79) 0.99 (223) Reference
A 0.03 (3) 0.01 (3) 0.19 (0.37-21.43) 2.81
G/G 0.93 (39) 0.97 (110) Reference
A/G 0.07 (1) 0.03 (3) 1.00 (0.02-12.11) 0.94
A/A 0.00 (1) 0.00 (0) Not calculable
India
(n = 76)
1000 Genomes-ASNb
(n = 286)
G 0.66 (99) 0.65 (371) Reference
A 0.34 (53) 0.35 (201) 1.00 (0.66-1.46) 0.99
G/G 0.39 (29) 0.43 (124) Reference
A/G 0.55 (41) 0.43 (123) 0.22 (0.81-2.54) 1.42
A/A 0.06 (6) 0.14 (39) 0.51 (0.21-1.78) 0.66
Brazil
(n = 113)
1000 Genomes-AMRc
(n = 199)
G 0.57 (144) 0.47 (169) Reference
A 0.43 (82) 0.53 (193) 0.00006 (0.35-0.71) 0.50
G/G 0.40 (52) 0.24 (44) Reference
A/G 0.34 (40) 0.45 (81) 0.002 (0.23-0.75) 0.42
A/A 0.26 (21) 0.31 (56) 0.0004 (0.16-0.63) 0.32
Italy
(n = 107)
HapMap-TSId
(n = 88)
G 0.36 (84) 0.33 (59) Reference
A 0.64 (130) 0.67 (117) 0.25 (0.50-1.21) 0.78
G/G 0.06 (15) 0.10 (9) Reference
A/G 0.61 (54) 0.47 (41) 0.65 (0.28-2.16) 0.79
A/A 0.33 (38) 0.43 (38) 0.35 (0.20-1.68) 0.60
a: Yoruba, Ibadan, Nigeria; b: an admixture from Han-Chinese in Beijng, China, Southern Han Chinese, Japanese in To-
kyo, Japan; c: an admixture of Colombian from Medellin, Colombia, Mexican ancestry from Los Angeles, United States of 
America, Puerto Ricans, from Puerto Rico; d: Toscans, Italy; CI: confidence interval; LTF: lactoferrin encoding gene; OR: 
odds ratio; SNP: single nucleotide polymorphism.
for African population; 0.51 for Indian populations and 
0.32 for Italian population). The unavailability of other 
samples did not allow us to increase the sample size; this 
was a limitation of our study that could affect the evalu-
ation of the potential role of LTF genetic variants in the 
context of susceptibility to HIV-1 infection.
It is also important to consider the difficulties in com-
paring LTF SNPs frequencies within the groups, also as-
suming that the populations studied are sets of individuals 
from different ethnic origins. However, even if the number 
of individuals is limited, we tried to replicate the associa-
tion findings in different ethnic groups, being aware that 
any replica and comparison within the four analysed groups 
is quite difficult due to the low frequency of LTF SNPs.
Previous findings suggested that lactotransferrin 
could play a role in HIV-1 vertical transmission, but no 
studies have been conducted on the ability of the two 
LTF variants to prevent HIV-1 entry to the cells or to 
interfere with the viral processes. Considering our nega-
tive results we could speculate that, although the two 
polymorphisms are not synonymous and result in two 
amino acidic substitutions, these variations may not 
modify the antiviral activity of the mature protein; the 
PolyPhen-2 (Adzhubei et al. 2010) software predicted the 
two SNPs as benign and thus not able to radically affect 
the protein. Another hypothesis is that if even the two 
polymorphisms could influence the antiviral role of the 
protein, perhaps an increment in gene expression, due to 
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TABLE V
LTF haplotype frequencies (and counts) in human immunodeficiency  
virus (HIV) positive (+) and negative (-) children in the four different populations analysed
LTF haplotypes
(Thr29Ala-Arg47Lys) HIV- HIV+
HIV- vs. HIV+
(p)
Africa n = 30 n = 52
AG 0.77 (23) 0.77 (40) 1.00
GG 0.20 (6) 0.19 (10)
GA 0.03 (1) 0.04 (2)
AA 0.00 (0) 0.00 (0)
LD (p; D’; r2) 0.07; 0.99; 0.11 0.01; 0.99; 0.13 -
India n = 62 n = 90
AG 0.47 (29) 0.39 (35) 0.56
GG 0.19 (12) 0.25 (23)
GA 0.34 (21) 0.36 (32)
AA 0.00 (0) 0.00 (0)
LD (p; D’; r2) < 0.01; 0.99; 0.45 < 0.01; 0.99; 0.35 -
Brazil n = 70 n = 156
AG 0.46 (32) 0.51 (79) 0.19
GA 0.37 (26) 0.32 (50)
GG 0.11 (8) 0.16 (25)
AA 0.06 (4) 0.01 (2)
LD (p; D’; r2) < 0.01; 0.72; 0.41 < 0.01; 0.91; 0.45 -
Italy n = 36 n = 178
GA 0.64 (23) 0.60 (106) 0.85
AG 0.25 (9) 0.30 (54)
GG 0.11 (4) 0.10 (17)
AA 0.00 (0) 0.01 (1)
LD (p; D’; r2) < 0.01; 0.99; 0.59 < 0.01; 0.97; 0.63 -
LD: linkage disequilibrium; LTF: lactoferrin encoding gene.
external factors other than genetic variations, may com-
pensate the alterations within the molecule. A study con-
ducted by Moreno-Navarrete et al. (2008) showed that 
the two LTF polymorphisms did not correlate with the 
plasma protein level in a Spanish population.
Unfortunately, in this study, being a retrospective 
one performed on historical groups of HIV-1 patients in-
fected trough vertical transmission, biological samples 
other than DNA were not available to perform functional 
studies and investigating the effective influence of LTF 
genetic variants on protein production or on protein 
functionality. Other limitations of the study are the lack 
of information about the mother’s genotypes and regard-
ing breastfeeding occurrence.
Our results suggest that LTF genetic polymorphisms 
Thr29Ala and Arg47Lys are not associated with suscep-
tibility to HIV-1 MTCT, but our data are preliminary, 
obtained on low number of individual, also lacking of 
functional characterisation of the analysed SNPs. There-
fore, further large-scale studies and functional analysis 
are necessary to clarify the potential role of LTF gene 
polymorphisms in HIV-1 infection susceptibility.
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